Trial
|
Studied treatment |
Control |
Patients |
Size |
Study type
|
Results |
NCT |
Heart failure - HR-slowing agents in all type of patients |
SHIFT, 2010 | ivabradine | placebo | | 6505 (3241/3264) | Confirmatory | | ISRCTN70429960 |
BEAUTIFUL, 2008 | ivabradine 15mg | placebo | | 10917 (5479/5438) | Confirmatory | | NCT00143507 |
Stable angina - HR-slowing agents in all type of patients - HR-slowing agents in patients with left ventricular dysfunction |
CL3-023 (15mg) | ivabradine | amlodipine | | 779 (381/398) | Confirmatory | | |
CL3-023 (20mg) | ivabradine | amlodipine | | 774 (376/398) | Confirmatory | | |
Borer (CL2-009) 10mg, 2003 | ivabradine 10mg | placebo | | 182 (91/91) | | | |
CL3-018 10mg | ivabradine 10mg | placebo on top of amlodipine | | 484 (232/252) | | | |
Ruzyllo (CL3-023) 15mg, 2007 | ivabradine 15mg | amlodipine | | 804 (400/404) | Confirmatory | | |
INITIATIVE (CL3-017, Tardif) 15mg, 2005 | ivabradine 15mg | atenolol | | 622 (315/307) | | | |
BEAUTIFUL, 2008 | ivabradine 15mg | placebo | | 10917 (5479/5438) | Confirmatory | | NCT00143507 |
BEAUTIFUL (angina subgroup) | ivabradine 15mg | placebo (on top standard treatment) | | 1507 (734/773) | Exploratory | | |
CL3-018 15mg | ivabradine 15mg | placebo on top of amlodipine | | 496 (244/252) | | | |
ASSOCIATE (Tardif), 2009 | ivabradine 15mg | placebo on top of atenolol | | 889 (449/440) | Confirmatory | | NCT00202566 |
Ruzyllo (CL3-023) 20mg, 2007 | ivabradine 20mg | amlodipine | | 795 (391/404) | Confirmatory | | |
INITIATIVE (CL3-017, Tardif) 20mg, 2005 | ivabradine 20mg | atenolol | | 624 (317/307) | Confirmatory | | |
SIGNIFY, 2014 | ivabradine 20mg | placebo | | 19102 (9550/9552) | | | ISRCTN61576291 |
Borer (CL2-009) 20mg, 2003 | ivabradine 20mg | placebo | | 179 (88/91) | | | |
Borer (CL2-009) 5mg, 2003 | ivabradine 5mg | placebo | | 181 (90/91) | | | |